{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:06:12Z","timestamp":1793297172207,"version":"4.5.0"},"reference-count":271,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The increasing incidence and changing epidemiology of invasive fungal infections continue to present many challenges to their effective management. The repertoire of antifungal drugs available for treatment is still limited although there are new antifungals on the horizon. Successful treatment of invasive mycoses is dependent on a mix of pathogen-, host- and antifungal drug-related factors. Laboratories need to be adept at detection of fungal pathogens in clinical samples in order to effectively guide treatment by identifying isolates with acquired drug resistance. While there are international guidelines on how to conduct in vitro antifungal susceptibility testing, these are not performed as widely as for bacterial pathogens. Furthermore, fungi generally are recovered in cultures more slowly than bacteria, and often cannot be cultured in the laboratory. Therefore, non-culture-based methods, including molecular tests, to detect fungi in clinical specimens are increasingly important in patient management and are becoming more reliable as technology improves. Molecular methods can also be used for detection of target gene mutations or other mechanisms that predict antifungal drug resistance. This review addresses acquired antifungal drug resistance in the principal human fungal pathogens and describes known resistance mechanisms and what in-house and commercial tools are available for their detection. It is emphasized that this approach should be complementary to culture-based susceptibility testing, given the range of mutations, resistance mechanisms and target genes that may be present in clinical isolates, but may not be included in current molecular assays.<\/jats:p>","DOI":"10.1093\/jac\/dkac161","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T19:12:10Z","timestamp":1651864330000},"page":"2053-2073","source":"Crossref","is-referenced-by-count":80,"title":["Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical implications"],"prefix":"10.1093","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4336-7729","authenticated-orcid":false,"given":"Thomas R","family":"Rogers","sequence":"first","affiliation":[{"name":"Department of Clinical Microbiology, Trinity College Dublin, St James\u2019s Hospital Campus , Dublin 8 , Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8600-9860","authenticated-orcid":false,"given":"Paul E","family":"Verweij","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Radboud University Medical Center , Nijmegen , The Netherlands"},{"name":"Center of Expertise in Mycology, Radboud umc\/CWZ , Nijmegen , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0126-1782","authenticated-orcid":false,"given":"Mariana","family":"Castanheira","sequence":"additional","affiliation":[{"name":"JMI Laboratories, North Liberty , IA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Dannaoui","sequence":"additional","affiliation":[{"name":"Unit\u00e9 de parasitologie-mycologie, service de microbiologie, h\u00f4pital europ\u00e9en Georges-Pompidou, AP-HP , Paris , France"},{"name":"Facult\u00e9 de m\u00e9decine, universit\u00e9 de Paris , Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P Lewis","family":"White","sequence":"additional","affiliation":[{"name":"Public Health Wales Microbiology Cardiff, UHW , Cardiff , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4747-0144","authenticated-orcid":false,"given":"Maiken Cavling","family":"Arendrup","sequence":"additional","affiliation":[{"name":"Unit of Mycology , Statens Serum Institut, Copenhagen , Denmark"},{"name":"Department of Clinical Microbiology, Rigshospitalet , Copenhagen , Denmark"},{"name":"Department of Clinical Medicine, University of Copenhagen , Copenhagen , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M C","family":"Arendrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Arikan-Akdagli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Barchiesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochem","family":"Buil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Castanheira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Chryssanthou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Friberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Guinea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Hamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingibjorg","family":"Hilmarsdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Klimko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Kurzai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Lagrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Lass-Fl\u00f6rl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Matos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Meletiadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Muehlethaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T R","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,6,15]]},"reference":[{"key":"2022072817544242200_dkac161-B1","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nchembio.1496","article-title":"Amphotericin forms an extramembranous and fungicidal sterol sponge","volume":"10","author":"Anderson","year":"2014","journal-title":"Nat Chem Biol"},{"key":"2022072817544242200_dkac161-B2","doi-asserted-by":"crossref","first-page":"104240","DOI":"10.1016\/j.bioorg.2020.104240","article-title":"History of the development of antifungal azoles: A review on structures, SAR, and mechanism of action","volume":"104","author":"Shafiei","year":"2020","journal-title":"Bioorg Chem"},{"key":"2022072817544242200_dkac161-B3","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/jac\/34.5.659","article-title":"High prevalence of antifungal resistance in Candida spp. from patients with AIDS","volume":"34","author":"Law","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"2022072817544242200_dkac161-B4","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1128\/AAC.46.6.1704-1713.2002","article-title":"Resistance mechanisms in clinical isolates of Candida albicans","volume":"46","author":"White","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B5","doi-asserted-by":"crossref","first-page":"e00029-17","DOI":"10.1128\/CMR.00029-17","article-title":"Candida auris: A review of the literature","volume":"31","author":"Jeffery-Smith","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"2022072817544242200_dkac161-B6","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3109\/13693786.2012.715763","article-title":"Fluconazole resistance in cryptococcal disease: Emerging or intrinsic?","volume":"51","author":"Cheong","year":"2013","journal-title":"Med Mycol"},{"key":"2022072817544242200_dkac161-B7","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1128\/AAC.41.6.1364","article-title":"Itraconazole resistance in Aspergillus fumigatus","volume":"41","author":"Denning","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B8","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/jac\/47.3.333","article-title":"Acquired itraconazole resistance in Aspergillus fumigatus","volume":"47","author":"Dannaoui","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"2022072817544242200_dkac161-B9","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1056\/NEJMc061720","article-title":"Multiple-triazole-resistant aspergillosis","volume":"356","author":"Verweij","year":"2007","journal-title":"N Engl J Med"},{"key":"2022072817544242200_dkac161-B10","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2022072817544242200_dkac161-B11","doi-asserted-by":"crossref","first-page":"e1002718","DOI":"10.1371\/journal.ppat.1002718","article-title":"Global analysis of the evolution and mechanism of echinocandin resistance in Candida glabrata","volume":"8","author":"Singh-Babak","year":"2012","journal-title":"PLoS Path"},{"key":"2022072817544242200_dkac161-B12","doi-asserted-by":"crossref","first-page":"e01277-17","DOI":"10.1128\/AAC.01277-17","article-title":"Emergence of echinocandin resistance due to a point mutation in the fks gene of Aspergillus fumigatus in a patient with chronic pulmonary aspergillosis","volume":"61","author":"Jim\u00e9nez-Ortigosa","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B13","doi-asserted-by":"crossref","first-page":"e00399-19","DOI":"10.1128\/AAC.00399-19","article-title":"Echinocandins for the treatment of invasive aspergillosis: From laboratory to bedside","volume":"63","author":"Aruanno","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B14","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1128\/AAC.00491-08","article-title":"In vitro activities at pH 5.0 and pH 7.0 and in vivo efficacy of flucytosine against Aspergillus fumigatus","volume":"52","author":"Verweij","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B15","doi-asserted-by":"crossref","first-page":"e02593-17","DOI":"10.1128\/AAC.02593-17","article-title":"Mechanistic basis of pH-dependent 5-flucytosine resistance in Aspergillus fumigatus","volume":"62","author":"Gsaller","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2165\/00003495-199958010-00018","article-title":"Terbinafine: an update of its use in superficial mycoses","volume":"58","author":"McClellan","year":"1999","journal-title":"Drugs"},{"key":"2022072817544242200_dkac161-B17","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/myc.13091","article-title":"Alarming India-wide phenomenon of antifungal resistance in dermatophytes: A multicentre study","volume":"63","author":"Ebert","year":"2020","journal-title":"Mycoses"},{"key":"2022072817544242200_dkac161-B18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3390\/jof6040207","article-title":"Spread of terbinafine-resistant Trichophyton mentagrophytes type VIII (India) in Germany: \u2018the tip of the iceberg?\u2019","volume":"6","author":"Nenoff","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"2022072817544242200_dkac161-B19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3390\/jof6040195","article-title":"Belgian national survey on Tinea capitis: Epidemiological considerations and highlight of terbinafine-resistant T. mentagrophytes with a mutation on SQLE Gene","volume":"6","author":"Sacheli","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"2022072817544242200_dkac161-B20","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3390\/jof7060419","article-title":"Molecular epidemiology and antifungal susceptibility of Trichophyton isolates in Greece: emergence of terbinafine-resistant Trichophyton mentagrophytes type VIII locally and globally","volume":"7","author":"Siopi","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"2022072817544242200_dkac161-B21","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/jdv.17241","article-title":"Emerging antifungal treatment failure of dermatophytosis in Europe: take care or it may become endemic","volume":"35","author":"Saunte","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2022072817544242200_dkac161-B22","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s11046-020-00455-8","article-title":"Trichophyton indotineae sp. nov.: A new highly terbinafine-resistant anthropophilic dermatophyte species","volume":"185","author":"Kano","year":"2020","journal-title":"Mycopathologia"},{"key":"2022072817544242200_dkac161-B23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11046-021-00544-2","article-title":"Taxonomy of the Trichophyton mentagrophytes\/T. interdigitale species complex harboring the highly virulent, multiresistant genotype T. indotineae","volume":"186","author":"Tang","year":"2021","journal-title":"Mycopathologia"},{"key":"2022072817544242200_dkac161-B24","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.3389\/fmicb.2019.02903","article-title":"A new age in molecular diagnostics for invasive fungal disease: are we ready?","volume":"10","author":"Kidd","year":"2020","journal-title":"Front Microbiol"},{"key":"2022072817544242200_dkac161-B25","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/femsre\/fuz015","article-title":"Recent trends in molecular diagnostics of yeast infections: from PCR to NGS","volume":"43","author":"Consortium Opathy","year":"2019","journal-title":"FEMS Microbiol Rev"},{"key":"2022072817544242200_dkac161-B26","doi-asserted-by":"crossref","first-page":"S259","DOI":"10.1093\/mmy\/myy159","article-title":"Recent advances and novel approaches in laboratory-based diagnostic mycology","volume":"57","author":"White","year":"2019","journal-title":"Med Mycol"},{"key":"2022072817544242200_dkac161-B27","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s15010-020-01395-7","article-title":"Clinical evaluation of an in-house panfungal real-time PCR assay for the detection of fungal pathogens","volume":"48","author":"Camp","year":"2020","journal-title":"Infection"},{"key":"2022072817544242200_dkac161-B28","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3389\/fmicb.2018.00740","article-title":"Overview of commercially available PCR assays for the detection of Aspergillus spp. DNA in patient samples","volume":"9","author":"Rath","year":"2018","journal-title":"Front Microbiol"},{"key":"2022072817544242200_dkac161-B29","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1128\/CMR.00095-16","article-title":"Molecular tools for the detection and deduction of azole antifungal drug resistance phenotypes in Aspergillus species","volume":"30","author":"Dudakova","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"2022072817544242200_dkac161-B30","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3389\/fmicb.2018.00515","article-title":"Molecular detection of azole-resistant Aspergillus fumigatus in clinical samples","volume":"9","author":"Buil","year":"2018","journal-title":"Front Microbiol"},{"key":"2022072817544242200_dkac161-B31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/jof6010012","article-title":"Detecting azole antifungal resistance in Aspergillus fumigatus by pyrosequencing","volume":"6","author":"van der Torre","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"2022072817544242200_dkac161-B32","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1128\/JCM.03216-14","article-title":"Validation of a new Aspergillus real-time PCR assay for direct detection of Aspergillus and azole resistance of Aspergillus fumigatus on bronchoalveolar lavage fluid","volume":"53","author":"Chong","year":"2015","journal-title":"J Clin Microbiol"},{"key":"2022072817544242200_dkac161-B33","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1128\/JCM.00520-17","article-title":"Culture-based methods and molecular tools for azole-resistant Aspergillus fumigatus detection in a Belgian University Hospital","volume":"55","author":"Montesinos","year":"2017","journal-title":"J Clin Microbiol"},{"key":"2022072817544242200_dkac161-B34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3390\/jof6020067","article-title":"High frequency direct detection of triazole resistance in Aspergillus fumigatus from patients with chronic pulmonary fungal diseases in India","volume":"6","author":"Singh","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"2022072817544242200_dkac161-B35","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/mmy\/myz002","article-title":"Use of Aspergillus fumigatus real-time PCR in broncho-alveolar lavage (BAL) samples for diagnosis of invasive aspergillosis, including azole-resistant cases, in high risk haematology patients: the need for a combined use with galactomannan","volume":"57","author":"Mikulska","year":"2019","journal-title":"Med Mycol"},{"key":"2022072817544242200_dkac161-B36","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3389\/fmicb.2018.00531","article-title":"Performance of molecular approaches for Aspergillus detection and azole resistance surveillance in cystic fibrosis","volume":"9","author":"Guegan","year":"2018","journal-title":"Front Microbiol"},{"key":"2022072817544242200_dkac161-B37","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1128\/JCM.01032-17","article-title":"Molecular diagnosis of invasive aspergillosis and detection of azole resistance by a newly commercialized PCR kit","volume":"55","author":"Dannaoui","year":"2017","journal-title":"J Clin Microbiol"},{"key":"2022072817544242200_dkac161-B38","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3390\/jof7020132","article-title":"Evaluation of three commercial PCR assays for the detection of azole-resistant Aspergillus fumigatus from respiratory samples of immunocompromised patients","volume":"7","author":"Scharmann","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"2022072817544242200_dkac161-B39","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/QCO.0000000000000111","article-title":"Echinocandin resistance: an emerging clinical problem?","volume":"27","author":"Arendrup","year":"2014","journal-title":"Curr Opin Infect Dis"},{"key":"2022072817544242200_dkac161-B40","doi-asserted-by":"crossref","first-page":"e00238-18","DOI":"10.1128\/AAC.00238-18","article-title":"Understanding echinocandin resistance in the emerging pathogen Candida auris","volume":"62","author":"Kordalewska","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B41","doi-asserted-by":"crossref","first-page":"e00630-19","DOI":"10.1128\/JCM.00630-19","article-title":"A rapid and automated sample-to-result Candida auris real-time PCR assay for high-throughput testing of surveillance samples with the BD Max Open System","volume":"57","author":"Leach","year":"2019","journal-title":"J Clin Microbiol"},{"key":"2022072817544242200_dkac161-B42","doi-asserted-by":"crossref","first-page":"e01126-19","DOI":"10.1128\/AAC.01126-19","article-title":"Emerging terbinafine resistance in Trichophyton: clinical characteristics, squalene epoxidase gene mutations and a reliable EUCAST method for detection","volume":"63","author":"Saunte","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B43","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/myc.13271","article-title":"Evaluation of DermaGenius\u00ae resistance real time polymerase reaction for detection of terbinafine-resistant Trichophyton species","volume":"64","author":"Singh","year":"2021","journal-title":"Mycoses"},{"key":"2022072817544242200_dkac161-B44","doi-asserted-by":"crossref","first-page":"856","DOI":"10.3390\/jof7100856","article-title":"Update on dihydropteroatesynthase (dhps) mutations in Pneumocystis jirovecii","volume":"7","author":"De la Horra","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"2022072817544242200_dkac161-B45","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.diagmicrobio.2016.10.005","article-title":"Evaluation of a new commercial real-time PCR assay for diagnosis of Pneumocystis jirovecii pneumonia and identification of dihydropteroate synthase (DHPS) mutations","volume":"87","author":"Montesinos","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2022072817544242200_dkac161-B46","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1473-3099(16)30138-4","article-title":"In-host adaptation and acquired triazole resistance in Aspergillus fumigatus: a dilemma for clinical management","volume":"16","author":"Verweij","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"2022072817544242200_dkac161-B47","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3389\/fmicb.2012.00439","article-title":"Ergosterol biosynthesis in Aspergillus fumigatus: its relevance as an antifungal target and role in antifungal drug resistance","volume":"3","author":"Alcazar-Fuoli","year":"2013","journal-title":"Front Microbiol"},{"key":"2022072817544242200_dkac161-B48","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3389\/fmicb.2019.00691","article-title":"The fungal CYP51s: their functions, structures, related drug resistance, and inhibitors","volume":"10","author":"Zhang","year":"2019","journal-title":"Front Microbiol"},{"key":"2022072817544242200_dkac161-B49","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.3201\/eid2607.200088","article-title":"Paradoxical trends in azole-resistant Aspergillus fumigatus in a national multicenter surveillance program, 2013\u20132018","volume":"26","author":"Lestrade","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"2022072817544242200_dkac161-B50","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1128\/AAC.00156-08","article-title":"Epidemiological cutoffs and cross resistance to azole drugs in Aspergillus fumigatus","volume":"52","author":"Rodriguez-Tudela","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B51","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1371\/journal.pmed.0050219","article-title":"Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism","volume":"5","author":"Snelders","year":"2008","journal-title":"PLoS Med"},{"key":"2022072817544242200_dkac161-B52","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.3201\/eid1710.110226","article-title":"Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007-2009","volume":"17","author":"van der Linden","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"2022072817544242200_dkac161-B53","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3201\/eid1507.090043","article-title":"Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure","volume":"15","author":"Howard","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"2022072817544242200_dkac161-B54","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1128\/AAC.00003-15","article-title":"Multiple cyp51A-based mechanisms identified in azole-resistant isolates of Aspergillus fumigatus from China","volume":"59","author":"Liu","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B55","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1128\/AAC.02234-15","article-title":"Azole resistance in Aspergillus fumigatus clinical isolates from an Italian culture collection","volume":"60","author":"Lazzarini","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B56","doi-asserted-by":"crossref","first-page":"pii=30300","DOI":"10.2807\/1560-7917.ES.2016.21.30.30300","article-title":"Emerging aspergillosis by azole-resistant Aspergillus fumigatus at an intensive care unit in the Netherlands, 2010 to 2013","volume":"21","author":"van Paassen","year":"2016","journal-title":"Euro Surveill"},{"key":"2022072817544242200_dkac161-B57","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/ina.12436","article-title":"Emergence of Aspergillus fumigatus azole resistance in azole-na\u00efve patients with chronic obstructive pulmonary disease and their homes","volume":"28","author":"Dauchy","year":"2018","journal-title":"Indoor Air"},{"key":"2022072817544242200_dkac161-B58","doi-asserted-by":"crossref","first-page":"e01549-17","DOI":"10.1128\/AAC.01549-17","article-title":"Elevated MIC values of imidazole drugs against Aspergillus fumigatus isolates with TR(34)\/L98H\/S297T\/F495I mutation","volume":"62","author":"Chen","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B59","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/jac\/dku009","article-title":"Prevalence and molecular characterization of azole resistance in Aspergillus spp. isolates from German cystic fibrosis patients","volume":"69","author":"Fischer","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"2022072817544242200_dkac161-B60","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.1128\/AAC.02855-14","article-title":"First detection of TR46\/Y121F\/T289A and TR34\/L98H alterations in Aspergillus fumigatus isolates from azole-naive patients in Denmark despite negative findings in the environment","volume":"58","author":"Astvad","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B61","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/jac\/dku364","article-title":"Azole, polyene and echinocandin MIC distributions for wild-type, TR34\/L98H and TR46\/Y121F\/T289A Aspergillus fumigatus isolates in the Netherlands","volume":"70","author":"van Ingen","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2022072817544242200_dkac161-B62","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/mmy\/myv029","article-title":"Prospective evaluation of azole resistance in Aspergillus fumigatus clinical isolates in France","volume":"53","author":"Choukri","year":"2015","journal-title":"Med Mycol"},{"key":"2022072817544242200_dkac161-B63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cmi.2016.04.001","article-title":"Azole-resistant Aspergillus fumigatus in Denmark: a laboratory-based study on resistance mechanisms and genotypes","volume":"22","author":"Jensen","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"2022072817544242200_dkac161-B64","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1093\/jac\/dkz258","article-title":"Prevalence of voriconazole-resistant invasive aspergillosis and its impact on mortality in haematology patients","volume":"74","author":"Resendiz-Sharpe","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2022072817544242200_dkac161-B65","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3201\/eid2501.171925","article-title":"Trends in azole resistance in Aspergillus fumigatus, the Netherlands, 1994-2016","volume":"25","author":"Buil","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"2022072817544242200_dkac161-B66","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1093\/jac\/dkx177","article-title":"In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates","volume":"72","author":"Buil","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2022072817544242200_dkac161-B67","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/jam.13488","article-title":"Azole-resistant Aspergillus fumigatus in sawmills of Eastern France","volume":"123","author":"Jeanvoine","year":"2017","journal-title":"J Appl Microbiol"},{"key":"2022072817544242200_dkac161-B68","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/cid\/ciy859","article-title":"Voriconazole resistance and mortality in invasive aspergillosis: A multicenter retrospective cohort study","volume":"68","author":"Lestrade","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2022072817544242200_dkac161-B69","doi-asserted-by":"crossref","first-page":"e2501-19","DOI":"10.1128\/AAC.02501-19","article-title":"A novel combination of CYP51A mutations confers pan-azole resistance in Aspergillus fumigatus","volume":"64","author":"Macedo","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B70","doi-asserted-by":"crossref","first-page":"5878","DOI":"10.1128\/AAC.01005-16","article-title":"Epidemiology and molecular characterizations of azole resistance in clinical and environmental Aspergillus fumigatus isolates from China","volume":"60","author":"Chen","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B71","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/jac\/dkz144","article-title":"One year prospective survey of azole resistance in Aspergillus fumigatus at a French cystic fibrosis reference centre: prevalence and mechanisms of resistance","volume":"74","author":"Lavergne","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2022072817544242200_dkac161-B72","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.ijantimicag.2017.01.004","article-title":"First isolation of the pan-azole-resistant Aspergillus fumigatus cyp51A TR46\/Y121F\/T289A mutant in a UK patient","volume":"49","author":"Moore","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"2022072817544242200_dkac161-B73","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.nmni.2015.04.005","article-title":"First detection of Aspergillus fumigatus azole-resistant strain due to Cyp51A TR46\/Y121F\/T289A in an azole-naive patient in Spain","volume":"6","author":"Pelaez","year":"2015","journal-title":"New Microbes New Infect"},{"key":"2022072817544242200_dkac161-B74","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/cid\/cit320","article-title":"Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles","volume":"57","author":"van der Linden","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2022072817544242200_dkac161-B75","doi-asserted-by":"crossref","first-page":"e00270-17","DOI":"10.1128\/AAC.00270-17","article-title":"Progressive dispersion of azole resistance in Aspergillus fumigatus: Fatal invasive aspergillosis in a patient with acute myeloid leukemia infected with an A. fumigatus strain with a cyp51A TR46 Y121F M172I T289A allele","volume":"61","author":"R\u00f6\u00dfler","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B76","doi-asserted-by":"crossref","first-page":"e00791-17","DOI":"10.1128\/mBio.00791-17","article-title":"A novel environmental azole resistance mutation in Aspergillus fumigatus and a possible role of sexual reproduction in its emergence","volume":"8","author":"Zhang","year":"2017","journal-title":"mBio"},{"key":"2022072817544242200_dkac161-B77","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/13693780802545600","article-title":"Multiple-azole-resistant Aspergillus fumigatus osteomyelitis in a patient with chronic granulomatous disease successfully treated with long-term oral posaconazole and surgery","volume":"47","author":"Hodiamont","year":"2009","journal-title":"Med Mycol"},{"key":"2022072817544242200_dkac161-B78","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3201\/eid2503.180297","article-title":"In vivo selection of a unique tandem repeat mediated azole resistance mechanism (TR(120)) in Aspergillus fumigatus cyp51A, Denmark","volume":"25","author":"Hare","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"2022072817544242200_dkac161-B79","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.3389\/fmicb.2018.01656","article-title":"Aspergillus species and antifungals susceptibility in clinical setting in the north of Portugal: Cryptic species and emerging azoles resistance in A. fumigatus","volume":"9","author":"Pinto","year":"2018","journal-title":"Front Microbiol"},{"key":"2022072817544242200_dkac161-B80","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ijantimicag.2006.08.017","article-title":"Multi-azole resistance in Aspergillus fumigatus","volume":"28","author":"Howard","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"2022072817544242200_dkac161-B81","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1128\/AAC.00517-11","article-title":"Interrogation of related clinical pan-azole resistant Aspergillus fumigatus strains: G138C, Y431C, and G434C single nucleotide polymorphisms in cyp51A, upregulation of cyp51A, and integration and activation of transposon Atf1 in the cyp51A promoter","volume":"55","author":"Albarrag","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B82","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.1128\/AAC.01141-13","article-title":"In vitro susceptibility of Aspergillus fumigatus to isavuconazole: correlation with itraconazole, voriconazole, and posaconazole","volume":"57","author":"Gregson","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B83","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.fgb.2011.08.002","article-title":"The structure-function relationship of the Aspergillus fumigatus cyp51A L98H conversion by site-directed mutagenesis: the mechanism of L98H azole resistance","volume":"48","author":"Snelders","year":"2011","journal-title":"Fungal Genet Biol"},{"key":"2022072817544242200_dkac161-B84","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S1473-3099(09)70265-8","article-title":"Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?","volume":"9","author":"Verweij","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"2022072817544242200_dkac161-B85","doi-asserted-by":"crossref","first-page":"31801","DOI":"10.1371\/journal.pone.0031801","article-title":"Triazole fungicides can induce cross-resistance to medical triazoles in Aspergillus fumigatus","volume":"7","author":"Snelders","year":"2012","journal-title":"PLoS One"},{"key":"2022072817544242200_dkac161-B86","doi-asserted-by":"crossref","first-page":"1007858","DOI":"10.1371\/journal.ppat.1007858","article-title":"The fading boundaries between patient and environmental routes of triazole resistance selection in Aspergillus fumigatus","volume":"15","author":"Buil","year":"2019","journal-title":"PLoS Pathog"},{"key":"2022072817544242200_dkac161-B87","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.3389\/fmicb.2020.01850","article-title":"Azole resistant Aspergillus fumigatus among Danish cystic fibrosis patients: increasing prevalence and dominance of TR34\/L98H","volume":"11","author":"Risum","year":"2020","journal-title":"Front Microbiol"},{"key":"2022072817544242200_dkac161-B88","doi-asserted-by":"crossref","first-page":"e02213-20","DOI":"10.1128\/mBio.02213-20","article-title":"Effects of agricultural fungicide use on Aspergillus fumigatus abundance, antifungal susceptibility, and population structure","volume":"11","author":"Barber","year":"2020","journal-title":"mBio"},{"key":"2022072817544242200_dkac161-B89","doi-asserted-by":"crossref","first-page":"50034","DOI":"10.1371\/journal.pone.0050034","article-title":"Discovery of a HapE mutation that causes azole resistance in Aspergillus fumigatus through whole genome sequencing and sexual crossing","volume":"7","author":"Camps","year":"2012","journal-title":"PLoS One"},{"key":"2022072817544242200_dkac161-B90","doi-asserted-by":"crossref","first-page":"202000729","DOI":"10.26508\/lsa.202000729","article-title":"Structural basis of HapE(P88L)-linked antifungal triazole resistance in Aspergillus fumigatus","volume":"3","author":"Hortschansky","year":"2020","journal-title":"Life Sci Alliance"},{"key":"2022072817544242200_dkac161-B91","doi-asserted-by":"crossref","first-page":"00437","DOI":"10.1128\/mBio.00437-19","article-title":"Mutations in hmg1, challenging the paradigm of clinical triazole resistance in Aspergillus fumigatus","volume":"10","author":"Rybak","year":"2019","journal-title":"mBio"},{"key":"2022072817544242200_dkac161-B92","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.3201\/eid2410.180730","article-title":"Non-cypA azole-resistant Aspergillus fumigatus isolates with mutation in HMG-CoA reductase","volume":"24","author":"Hagiwara","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"2022072817544242200_dkac161-B93","doi-asserted-by":"crossref","first-page":"e00263-21","DOI":"10.1128\/AAC.00263-21","article-title":"Emergence of W272C substitution in Hmg1 in a triazole-resistant isolate of Aspergillus fumigatus from a Chinese patient with chronic cavitary pulmonary aspergillosis","volume":"65","author":"Liang","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B94","doi-asserted-by":"crossref","first-page":"e1089-21","DOI":"10.1128\/AAC.01089-21","article-title":"Triazole-resistant Aspergillus fumigatus in an Israeli patient with chronic cavitary pulmonary aspergillosis due to a novel E306K substitution in Hmg1","volume":"65","author":"Handelman","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B95","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/jac\/dks451","article-title":"High-level expression of cyp51B in azole-resistant clinical Aspergillus fumigatus isolates","volume":"68","author":"Buied","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"2022072817544242200_dkac161-B96","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/jac\/dkt075","article-title":"The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus","volume":"68","author":"Fraczek","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"2022072817544242200_dkac161-B97","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1087-1845(02)00016-6","article-title":"Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate","volume":"36","author":"Slaven","year":"2002","journal-title":"Fungal Genet Biol"},{"key":"2022072817544242200_dkac161-B98","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1128\/AAC.05027-11","article-title":"SREBP-dependent triazole susceptibility in Aspergillus fumigatus is mediated through direct transcriptional regulation of erg11A (cyp51A)","volume":"56","author":"Blosser","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B99","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41467-019-14191-1","article-title":"The negative cofactor 2 complex is a key regulator of drug resistance in Aspergillus fumigatus","volume":"11","author":"Furukawa","year":"2020","journal-title":"Nat Commun"},{"key":"2022072817544242200_dkac161-B100","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3390\/jof6040227","article-title":"Hmg1 gene mutation prevalence in triazole-resistant Aspergillus fumigatus clinical isolates","volume":"6","author":"Resendiz-Sharpe","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"2022072817544242200_dkac161-B101","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"2022072817544242200_dkac161-B102","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.cmi.2018.09.008","article-title":"Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST). How to: EUCAST recommendations on the screening procedure E.Def 10.1 for the detection of azole resistance in Aspergillus fumigatus isolates using four-well azole-containing agar plates","volume":"25","author":"Guinea","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"2022072817544242200_dkac161-B103","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.cmi.2020.06.007","article-title":"How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European Committee on antimicrobial susceptibility testing (EUCAST)","volume":"26","author":"Arendrup","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"2022072817544242200_dkac161-B104","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1128\/JCM.00411-17","article-title":"Analytical and clinical evaluation of the PathoNostics AsperGenius assay for detection of invasive aspergillosis and resistance to azole antifungal drugs directly from plasma samples","volume":"55","author":"White","year":"2017","journal-title":"J Clin Microbiol"},{"key":"2022072817544242200_dkac161-B105","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1093\/jac\/dkw323","article-title":"PCR-based detection of Aspergillus fumigatus Cyp51A mutations on bronchoalveolar lavage: a multicentre validation of the AsperGenius assay in 201 patients with haematological disease suspected for invasive aspergillosis","volume":"71","author":"Chong","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"2022072817544242200_dkac161-B106","doi-asserted-by":"crossref","first-page":"e00865-19","DOI":"10.1128\/AAC.00865-19","article-title":"Molecular identification, antifungal susceptibility testing, and mechanisms of azole resistance in Aspergillus species received within a surveillance program on antifungal resistance in Spain","volume":"63","author":"Rivero-Menendez","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B107","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3389\/fmicb.2018.00516","article-title":"Azole-resistance in Aspergillus terreus and related species: an emerging problem or a rare phenomenon?","volume":"9","author":"Zoran","year":"2018","journal-title":"Front Microbiol"},{"key":"2022072817544242200_dkac161-B108","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.3390\/genes11101217","article-title":"Point mutations in the 14-\u03b1 sterol demethylase cyp51A or cyp51C could contribute to azole resistance in Aspergillus flavus","volume":"11","author":"Lucio","year":"2020","journal-title":"Genes (Basel)"},{"key":"2022072817544242200_dkac161-B109","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1128\/AAC.05477-11","article-title":"The T788G mutation in the cyp51C gene confers voriconazole resistance in Aspergillus flavus causing aspergillosis","volume":"56","author":"Liu","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B110","doi-asserted-by":"crossref","first-page":"e01610-18","DOI":"10.1128\/AAC.01610-18","article-title":"Microsatellite typing and resistance mechanism analysis of voriconazole-resistant Aspergillus flavus isolates in South Korean hospitals","volume":"63","author":"Choi","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B111","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1128\/AAC.00190-08","article-title":"Establishing in vitro-in vivo correlations for Aspergillus fumigatus: the challenge of azoles versus echinocandins","volume":"52","author":"Arendrup","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B112","doi-asserted-by":"crossref","first-page":"e00779-19","DOI":"10.1128\/mBio.00779-19","article-title":"Stress-Induced Changes in the Lipid Microenvironment of \u03b2-(1,3)-d-Glucan Synthase Cause Clinically Important Echinocandin Resistance in Aspergillus fumigatus","volume":"10","author":"Satish","year":"2019","journal-title":"mBio"},{"key":"2022072817544242200_dkac161-B113","doi-asserted-by":"crossref","first-page":"e00906-17","DOI":"10.1128\/AAC.00906-17","article-title":"Monitoring antifungal resistance in a global collection of invasive yeasts and moulds: Application of CLSI epidemiological cutoff values and whole genome sequencing analysis for detection of azole resistance in Candida albicans","volume":"61","author":"Castanheira","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B114","doi-asserted-by":"crossref","first-page":"105799","DOI":"10.1016\/j.ijantimicag.2019.09.003","article-title":"Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination","volume":"55","author":"Castanheira","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"2022072817544242200_dkac161-B115","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1093\/ofid\/ofy358","article-title":"Twenty years of the SENTRY Antifungal Surveillance Program: Results for Candida species From 1997-2016","volume":"6","author":"Pfaller","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2022072817544242200_dkac161-B116","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/jac\/dkv140","article-title":"Stepwise emergence of azole, echinocandin, and amphotericin B multidrug resistance in vivo in Candida albicans orchestrated by multiple genetic alterations","volume":"70","author":"Jensen","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2022072817544242200_dkac161-B117","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/jac\/dks481","article-title":"Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China","volume":"68","author":"Jiang","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"2022072817544242200_dkac161-B118","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1473-3099(02)00181-0","article-title":"Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences","volume":"2","author":"Sanglard","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"2022072817544242200_dkac161-B119","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1567-1364.2009.00578.x","article-title":"Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation","volume":"9","author":"Sanglard","year":"2009","journal-title":"FEMS Yeast Res"},{"key":"2022072817544242200_dkac161-B120","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.diagmicrobio.2009.11.006","article-title":"Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature","volume":"66","author":"Morio","year":"2010","journal-title":"Diag Microbiol Infect Dis"},{"key":"2022072817544242200_dkac161-B121","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/AAC.03470-14","article-title":"Contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicans","volume":"59","author":"Flowers","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B122","doi-asserted-by":"crossref","first-page":"915.e5","DOI":"10.1016\/j.cmi.2021.02.006","article-title":"In vitro activity of ibrexafungerp and comparators against Candida albicans genotypes from vaginal samples and blood cultures","volume":"27","author":"Mesquida","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"2022072817544242200_dkac161-B123","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1128\/AAC.00477-13","article-title":"Candida tropicalis antifungal cross-resistance is related to different azole target (Erg11p) modifications","volume":"57","author":"Forastiero","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B124","doi-asserted-by":"crossref","first-page":"e03333-20","DOI":"10.1128\/mBio.03333-20","article-title":"Genome-wide analysis of experimentally evolved Candida auris reveals multiple novel mechanisms of multidrug resistance","volume":"12","author":"Carolus","year":"2021","journal-title":"mBio"},{"key":"2022072817544242200_dkac161-B125","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/cid\/ciw691","article-title":"Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses","volume":"64","author":"Lockhart","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2022072817544242200_dkac161-B126","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1128\/AAC.00348-10","article-title":"Identification and characterization of four azole-resistant erg3 mutants of Candida albicans","volume":"54","author":"Martel","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B127","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/AAC.02157-15","article-title":"Activity of isavuconazole and other azoles against Candida clinical isolates and yeast model systems with known azole resistance mechanisms","volume":"60","author":"Sanglard","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B128","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1128\/EC.00069-09","article-title":"Functional analysis of cis- and trans-acting elements of the Candida albicans CDR2 promoter with a novel promoter reporter system","volume":"8","author":"Coste","year":"2009","journal-title":"Eukaryot Cell"},{"key":"2022072817544242200_dkac161-B129","doi-asserted-by":"crossref","first-page":"e01342-17","DOI":"10.1128\/AAC.01342-17","article-title":"Mediator tail module is required for Tac1-activated CDR1 expression and azole resistance in Candida albicans","volume":"61","author":"Liu","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B130","doi-asserted-by":"crossref","first-page":"e00078-19","DOI":"10.1128\/AAC.00078-19","article-title":"Contribution of clinically derived mutations in the gene encoding the zinc cluster transcription factor Mrr2 to fluconazole antifungal resistance and CDR1 expression in Candida albicans","volume":"63","author":"Nishimoto","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B131","doi-asserted-by":"crossref","first-page":"e17589","DOI":"10.1371\/journal.pone.0017589","article-title":"Contribution of CgPDR1-regulated genes in enhanced virulence of azole-resistant Candida glabrata","volume":"6","author":"Ferrari","year":"2011","journal-title":"PLoS One"},{"key":"2022072817544242200_dkac161-B132","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1371\/journal.ppat.0030164","article-title":"The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans","volume":"3","author":"Morschhauser","year":"2007","journal-title":"PLoS Pathog"},{"key":"2022072817544242200_dkac161-B133","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2958.2012.08210.x","article-title":"The stepwise acquisition of fluconazole resistance mutations causes a gradual loss of fitness in Candida albicans","volume":"86","author":"Sasse","year":"2012","journal-title":"Mol Microbiol"},{"key":"2022072817544242200_dkac161-B134","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/1471-2180-9-167","article-title":"Rapid detection of EG11 gene mutations in clinical Candida albicans isolates with reduced susceptibility to fluconazole by rolling circle amplification and DNA sequencing","volume":"9","author":"Wang","year":"2009","journal-title":"BMC Microbiol"},{"issue":"Suppl 6","key":"2022072817544242200_dkac161-B135","doi-asserted-by":"crossref","first-page":"S604","DOI":"10.1093\/cid\/civ814","article-title":"Echinocandins: The expanding antifungal armamentarium","volume":"61","author":"Aguilar-Zapata","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2022072817544242200_dkac161-B136","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.drup.2007.04.002","article-title":"Resistance to echinocandin-class antifungal drugs","volume":"10","author":"Perlin","year":"2007","journal-title":"Drug Resist Updat"},{"key":"2022072817544242200_dkac161-B137","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.fgb.2009.09.003","article-title":"Fungal echinocandin resistance","volume":"47","author":"Walker","year":"2010","journal-title":"Fungal Genet Biol"},{"key":"2022072817544242200_dkac161-B138","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12281-014-0209-7","article-title":"Epidemiology of echinocandin resistance in Candida","volume":"8","author":"Grossman","year":"2014","journal-title":"Curr Fungal Infect Rep"},{"key":"2022072817544242200_dkac161-B139","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/cit136","article-title":"Increasing echinocandin resistance in Candida glabrata: Clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations","volume":"56","author":"Alexander","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2022072817544242200_dkac161-B140","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.1128\/AAC.00836-10","article-title":"FKS mutations and elevated echinocandin MIC values among Candida glabrata isolates from U.S. population-based surveillance","volume":"54","author":"Zimbeck","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B141","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3390\/jof7060491","article-title":"Update 2016-2018 of the nationwide Danish fungaemia surveillance study: epidemiologic changes in a 15-year perspective","volume":"7","author":"Risum","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"2022072817544242200_dkac161-B142","doi-asserted-by":"crossref","first-page":"e01827","DOI":"10.1128\/AAC.01827-20","article-title":"Monitoring the epidemiology and antifungal resistance of yeasts causing fungemia in a tertiary care hospital in Madrid, Spain: Any relevant changes in the last 13 years?","volume":"65","author":"D\u00edaz-Garcia","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B143","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1128\/AAC.00123-14","article-title":"Positions and numbers of FKS mutations in Candida albicans selectively influence in vitro and in vivo susceptibilities to echinocandin treatment","volume":"58","author":"Lackner","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B144","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/AAC.01674-13","article-title":"Frequency of fks mutations among Candida glabrata isolates from a 10-year global collection of bloodstream infection isolates","volume":"58","author":"Castanheira","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B145","doi-asserted-by":"crossref","first-page":"e02438-19","DOI":"10.1128\/AAC.02438-19","article-title":"Rezafungin in vitro activity against contemporary Nordic clinical Candida isolates and Candida auris determined by the EUCAST reference method","volume":"64","author":"Helleberg","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B146","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz262","article-title":"Development of high-level echinocandin resistance in a patient with recurrent Candida auris candidemia secondary to chronic candiduria","author":"Biagi","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2022072817544242200_dkac161-B147","doi-asserted-by":"crossref","first-page":"e01811-18","DOI":"10.1128\/AAC.01811-18","article-title":"Rapid detection of ERG11-associated azole resistance and FKS-associated echinocandin resistance in Candida auris","volume":"63","author":"Hou","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B148","doi-asserted-by":"crossref","first-page":"e02299-17","DOI":"10.1128\/AAC.02299-17","article-title":"FKS2 and FKS3 genes of opportunistic human pathogen Candida albicans influence echinocandin susceptibility","volume":"62","author":"Suwunnakorn","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B149","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s10096-014-2096-9","article-title":"Emergence of echinocandin-resistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy?","volume":"33","author":"Fekkar","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"Suppl 6","key":"2022072817544242200_dkac161-B150","doi-asserted-by":"crossref","first-page":"S612","DOI":"10.1093\/cid\/civ791","article-title":"Echinocandin resistance in Candida","volume":"61","author":"Perlin","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2022072817544242200_dkac161-B151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/nyas.12831","article-title":"Mechanisms of echinocandin antifungal drug resistance","volume":"1354","author":"Perlin","year":"2015","journal-title":"Ann N Y Acad Sciences"},{"key":"2022072817544242200_dkac161-B152","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/cid\/ciu407","article-title":"FKS mutant Candida glabrata: Risk factors and outcomes in patients with candidemia","volume":"59","author":"Beyda","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2022072817544242200_dkac161-B153","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s12281-011-0053-y","article-title":"Definitions and epidemiology of Candida species not susceptible to echinocandins","volume":"5","author":"Pfaller","year":"2011","journal-title":"Curr Fungal Infect Rep"},{"key":"2022072817544242200_dkac161-B154","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/QCO.0000000000000215","article-title":"Clinical perspectives on echinocandin resistance among Candida species","volume":"28","author":"Shields","year":"2015","journal-title":"Curr Opin Infect Dis"},{"key":"2022072817544242200_dkac161-B155","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s40265-014-0286-5","article-title":"Echinocandin resistance, susceptibility testing and prophylaxis: implications for patient management","volume":"74","author":"Perlin","year":"2014","journal-title":"Drugs"},{"key":"2022072817544242200_dkac161-B156","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1128\/AAC.00959-08","article-title":"Pyrosequencing to detect mutations in FKS1 that confer reduced echinocandin susceptibility in Candida albicans","volume":"52","author":"Wiederhold","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B157","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1093\/jac\/dkv139","article-title":"Next-generation sequencing offers new insights into the resistance of Candida spp. to echinocandins and azoles","volume":"70","author":"Garnaud","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2022072817544242200_dkac161-B158","doi-asserted-by":"crossref","first-page":"S445","DOI":"10.1093\/infdis\/jix131","article-title":"Multidrug-resistant Candida: epidemiology, molecular mechanisms, and treatment","volume":"216","author":"Arendrup","year":"2017","journal-title":"J Infect Dis"},{"key":"2022072817544242200_dkac161-B159","doi-asserted-by":"crossref","first-page":"e01791-16","DOI":"10.1128\/AAC.01791-16","article-title":"Clinical and microbiological characteristics of breakthrough candidemia in allogeneic hematopoietic stem cell transplant recipients in a Japanese hospital","volume":"61","author":"Kimura","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B160","doi-asserted-by":"crossref","first-page":"e0135110","DOI":"10.1371\/journal.pone.0135110","article-title":"New mechanisms of flucytosine resistance in C. glabrata unveiled by a chemogenomics analysis in S. cerevisiae","volume":"10","author":"Costa","year":"2015","journal-title":"PLoS One"},{"key":"2022072817544242200_dkac161-B161","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3390\/jof6040321","article-title":"Amphotericin B and other polyenes\u2013discovery, clinical use, mode of action and drug resistance","volume":"6","author":"Carolus","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"2022072817544242200_dkac161-B162","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1111\/1469-0691.12495","article-title":"Antifungal drug resistance mechanisms in pathogenic fungi: from bench to bedside","volume":"20","author":"Cuenca-Estrella","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"2022072817544242200_dkac161-B163","first-page":"2452","article-title":"Detection of FUR1 gene in 5-flucytosine resistant Candida isolates in vaginal candidiasis patients","volume":"7","author":"Gopinathan","year":"2013","journal-title":"J Clin Diagn Res"},{"key":"2022072817544242200_dkac161-B164","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1128\/AAC.48.6.2223-2227.2004","article-title":"Clade-specific flucytosine resistance is due to a single nucleotide change in the FUR1 gene of Candida albicans","volume":"48","author":"Dodgson","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B165","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2022072817544242200_dkac161-B166","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2022072817544242200_dkac161-B167","article-title":"Guidelines on the diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children: supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva: WHO 2018","author":"WHO"},{"key":"2022072817544242200_dkac161-B168","first-page":"203","volume-title":"Cryptococcus. American Society of Microbiology","author":"Pfaller","year":"2011"},{"key":"2022072817544242200_dkac161-B169","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1128\/AAC.49.7.2851-2856.2005","article-title":"Cryptococcus neoformans resistance to echinocandins: (1,3)\u03b2-glucan synthase activity is sensitive to echinocandins","volume":"49","author":"Maligie","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B170","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1054\/drup.1999.0090","article-title":"Drug resistance in Cryptococcus neoformans","volume":"2","author":"Perfect","year":"1999","journal-title":"Drug Resist Updat"},{"key":"2022072817544242200_dkac161-B171","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/jac\/dkh361","article-title":"Increasing in vitro resistance to fluconazole in Cryptococcus neoformans Cambodian isolates: April 2000 to March 2002","volume":"54","author":"Sar","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"2022072817544242200_dkac161-B172","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1086\/507895","article-title":"Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution","volume":"43","author":"Bicanic","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2022072817544242200_dkac161-B173","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/myc.12747","article-title":"A systematic review of fluconazole resistance in clinical isolates of Cryptococcus species","volume":"61","author":"Bongomin","year":"2018","journal-title":"Mycoses"},{"key":"2022072817544242200_dkac161-B174","doi-asserted-by":"crossref","first-page":"e01179--17","DOI":"10.1128\/AAC.01179-17","article-title":"Environmental triazole induces cross-resistance to clinical drugs and affects morphophysiology and virulence of Cryptococcus gattii and C. neoformans","volume":"62","author":"Bastos","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B175","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.scitotenv.2019.05.094","article-title":"From the environment to the host: How non-azole agrochemical exposure affects the antifungal susceptibility and virulence of Cryptococcus gattii","volume":"681","author":"Bastos","year":"2019","journal-title":"Sci Total Environ"},{"key":"2022072817544242200_dkac161-B176","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s12281-020-00373-8","article-title":"Could fungicides lead to azole drug resistance in a cross-resistance manner among environmental Cryptococcus strains?","volume":"14","author":"Takahashi","year":"2020","journal-title":"Curr Fungal Infect Rep"},{"key":"2022072817544242200_dkac161-B177","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1128\/AAC.3.6.649","article-title":"5-fluorocytosine resistance in Cryptococcus neoformans","volume":"3","author":"Block","year":"1973","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B178","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1086\/514669","article-title":"Flucytosine monotherapy for cryptococcosis","volume":"27","author":"Hospenthal","year":"1998","journal-title":"Clin Infect Dis"},{"key":"2022072817544242200_dkac161-B179","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1128\/IAI.74.2.1352-1359.2006","article-title":"Role of AFR1, an ABC transporter-encoding gene, in the in vivo response to fluconazole and virulence of Cryptococcus neoformans","volume":"74","author":"Sanguinetti","year":"2006","journal-title":"Infect Immun"},{"key":"2022072817544242200_dkac161-B180","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1128\/AAC.50.1.113-120.2006","article-title":"Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis","volume":"50","author":"Schwarz","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B181","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/infdis\/168.2.508","article-title":"Correlation of in vitro azole susceptibility with in vivo response in a murine model of cryptococcal meningitis","volume":"168","author":"Velez","year":"1993","journal-title":"J Infect Dis"},{"key":"2022072817544242200_dkac161-B182","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/0014-5793(95)00684-2","article-title":"Resistant P45051A1 activity in azole antifungal tolerant Cryptococcus neoformans from AIDS patients","volume":"368","author":"Lamb","year":"1995","journal-title":"FEBS Lett"},{"key":"2022072817544242200_dkac161-B183","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1128\/AAC.41.4.748","article-title":"Fluconazole tolerance in clinical isolates of Cryptococcus neoformans","volume":"41","author":"Venkateswarlu","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B184","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1128\/AAC.47.11.3653-3656.2003","article-title":"G484S amino acid substitution in lanosterol 14-alpha demethylase (ERG11) is related to fluconazole resistance in a recurrent Cryptococcus neoformans clinical isolate","volume":"47","author":"Rodero","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B185","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1128\/AAC.05502-11","article-title":"Identification of a Cryptococcus neoformans cytochrome P450 lanosterol 14alpha-demethylase (Erg11) residue critical for differential susceptibility between fluconazole\/voriconazole and itraconazole\/posaconazole","volume":"56","author":"Sionov","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B186","first-page":"137","article-title":"Amino acid substitution in Cryptococcus neoformans lanosterol 14-alpha-demethylase involved in fluconazole resistance in clinical isolates","volume":"48","author":"Bosco-Borgeat","year":"2016","journal-title":"Rev Argent Microbiol"},{"key":"2022072817544242200_dkac161-B187","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/myc.12543","article-title":"Molecular identification, antifungal resistance and virulence of Cryptococcus neoformans and Cryptococcus deneoformans isolated in Seville, Spain","volume":"60","author":"Gago","year":"2017","journal-title":"Mycoses"},{"key":"2022072817544242200_dkac161-B188","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/mmy\/myw101","article-title":"Multi-azole-resistant strains of Cryptococcus neoformans var. grubii isolated from a FLZ-resistant strain by culturing in medium containing voriconazole","volume":"55","author":"Kano","year":"2017","journal-title":"Med Mycol"},{"key":"2022072817544242200_dkac161-B189","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11046-015-9919-9","article-title":"First isolation of azole-resistant Cryptococcus neoformans from feline cryptococcosis","volume":"180","author":"Kano","year":"2015","journal-title":"Mycopathologia"},{"key":"2022072817544242200_dkac161-B190","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1128\/AAC.39.7.1526","article-title":"Cross-resistance to polyene and azole drugs in Cryptococcus neoformans","volume":"39","author":"Joseph-Horne","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B191","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/jac\/dku554","article-title":"Identification and properties of plasma membrane azole efflux pumps from the pathogenic fungi Cryptococcus gattii and Cryptococcus neoformans","volume":"70","author":"Basso","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2022072817544242200_dkac161-B192","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1365-2958.2003.03281.x","article-title":"Identification and characterization of a Cryptococcus neoformans ATP binding cassette (ABC) transporter-encoding gene, CnAFR1, involved in the resistance to fluconazole","volume":"47","author":"Posteraro","year":"2003","journal-title":"Mol Microbiol"},{"key":"2022072817544242200_dkac161-B193","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1128\/AAC.43.8.1856","article-title":"Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans","volume":"43","author":"Mondon","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B194","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1128\/AAC.45.2.420-427.2001","article-title":"Dynamic and heterogeneous mutations to fluconazole resistance in Cryptococcus neoformans","volume":"45","author":"Xu","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B195","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1128\/JCM.41.1.267-272.2003","article-title":"Characterization of heteroresistance to fluconazole among clinical isolates of Cryptococcus neoformans","volume":"41","author":"Yamazumi","year":"2003","journal-title":"J Clin Microbiol"},{"key":"2022072817544242200_dkac161-B196","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1128\/AAC.00295-09","article-title":"Heteroresistance to fluconazole in Cryptococcus neoformans is intrinsic and associated with virulence","volume":"53","author":"Sionov","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B197","doi-asserted-by":"crossref","first-page":"e1000848","DOI":"10.1371\/journal.ppat.1000848","article-title":"Cryptococcus neoformans overcomes stress of azole drugs by formation of disomy in specific multiple chromosomes","volume":"6","author":"Sionov","year":"2010","journal-title":"PLoS Pathog"},{"key":"2022072817544242200_dkac161-B198","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1128\/AAC.00694-13","article-title":"Azole heteroresistance in Cryptococcus neoformans: emergence of resistant clones with chromosomal disomy in the mouse brain during fluconazole treatment","volume":"57","author":"Sionov","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B199","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1172\/JCI124516","article-title":"Dynamic ploidy changes drive fluconazole resistance in human cryptococcal meningitis","volume":"129","author":"Stone","year":"2019","journal-title":"J Clin Invest"},{"key":"2022072817544242200_dkac161-B200","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1128\/AAC.00153-10","article-title":"Heteroresistance of Cryptococcus gattii to fluconazole","volume":"54","author":"Varma","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B201","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0378-1119(97)00421-6","article-title":"Cloning and characterization of CneMDR1: a Cryptococcus neoformans gene encoding a protein related to multidrug resistance proteins","volume":"201","author":"Thornewell","year":"1997","journal-title":"Gene"},{"key":"2022072817544242200_dkac161-B202","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1128\/CMR.00058-14","article-title":"Antimicrobial heteroresistance: an emerging field in need of clarity","volume":"28","author":"El-Halfawy","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"2022072817544242200_dkac161-B203","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/myc.12639","article-title":"Heteroresistance and fungi","volume":"60","author":"Ferreira","year":"2017","journal-title":"Mycoses"},{"key":"2022072817544242200_dkac161-B204","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1128\/AAC.7.1.99","article-title":"Relationship between polyene resistance and sterol compositions in Cryptococcus neoformans","volume":"7","author":"Kim","year":"1975","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B205","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1574-6968.1994.tb07140.x","article-title":"Resistance to amphotericin B associated with defective sterol delta 8\u2013&gt;7 isomerase in a Cryptococcus neoformans strain from an AIDS patient","volume":"122","author":"Kelly","year":"1994","journal-title":"FEMS Microbiol Lett"},{"key":"2022072817544242200_dkac161-B206","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/jac\/46.2.171","article-title":"Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions","volume":"46","author":"Vermes","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"2022072817544242200_dkac161-B207","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/10408418709104447","article-title":"The genetic basis of resistance to 5-fluorocytosine in Candida species and Cryptococcus neoformans","volume":"15","author":"Whelan","year":"1987","journal-title":"Crit Rev Microbiol"},{"key":"2022072817544242200_dkac161-B208","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/mmy\/myx135","article-title":"Flucytosine resistance in Cryptococcus gattii is indirectly mediated by the FCY2-FCY1-FUR1 pathway","volume":"56","author":"Vu","year":"2018","journal-title":"Med Mycol"},{"key":"2022072817544242200_dkac161-B209","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41467-019-13890-z","article-title":"5-fluorocytosine resistance is associated with hypermutation and alterations in capsule biosynthesis in Cryptococcus","volume":"11","author":"Billmyre","year":"2020","journal-title":"Nature Comm"},{"key":"2022072817544242200_dkac161-B210","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1128\/AAC.00446-06","article-title":"Combination of amphotericin B with flucytosine is active in vitro against flucytosine-resistant isolates of Cryptococcus neoformans","volume":"51","author":"Schwarz","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B211","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11046-015-9902-5","article-title":"Successful treatment of refractory Majocchi\u2019s Granuloma with voriconazole and review of published literature","volume":"180","author":"Liu","year":"2015","journal-title":"Mycopathologia"},{"key":"2022072817544242200_dkac161-B212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/tid.12799","article-title":"Severe dermatophytosis in solid organ transplant recipients: A French retrospective series and literature review","volume":"20","author":"Rouzaud","year":"2018","journal-title":"Transpl Infect Dis"},{"key":"2022072817544242200_dkac161-B213","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1128\/AAC.49.7.2840-2844.2005","article-title":"Amino acid substitution in Trichophyton rubrum squalene epoxidase associated with resistance to terbinafine","volume":"49","author":"Osborne","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B214","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.00115-17","article-title":"Terbinafine resistance of Trichophyton clinical isolates caused by specific point mutations in the squalene epoxidase gene","volume":"61","author":"Yamada","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B215","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000277762","article-title":"Onychomycosis insensitive to systemic terbinafine and azole treatments reveals non-dermatophyte moulds as infectious agents","volume":"220","author":"Baudraz-Rosselet","year":"2010","journal-title":"Dermatology"},{"key":"2022072817544242200_dkac161-B216","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.mycmed.2019.100913","article-title":"Antifungal resistance in dermatophytes: Emerging problem and challenge for the medical community","volume":"29","author":"Monod","year":"2019","journal-title":"J Med Mycol"},{"key":"2022072817544242200_dkac161-B217","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1292\/jvms.17-0680","article-title":"The first report of terbinafine resistance Microsporum canis from a cat","volume":"80","author":"Hsiao","year":"2018","journal-title":"J Vet Med Sci"},{"key":"2022072817544242200_dkac161-B218","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3390\/jof8020150","article-title":"Increasing terbinafine resistance in Danish Trichophyton isolates 2019-2020","volume":"8","author":"Astvad","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"2022072817544242200_dkac161-B219","doi-asserted-by":"crossref","DOI":"10.1007\/s00248-021-01866-w","article-title":"European hedgehogs (Erinaceus europaeus L.) as a reservoir of dermatophytes in Poland","author":"Gnat","year":"2021","journal-title":"Microb Ecol"},{"key":"2022072817544242200_dkac161-B220","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1099\/jmm.0.46542-0","article-title":"Evaluation of susceptibility of Trichophyton mentagrophytes and Trichophyton rubrum clinical isolates to antifungal drugs using a modified CLSI microdilution method (M38-A)","volume":"56","author":"Barros","year":"2007","journal-title":"J Med Microbiol"},{"key":"2022072817544242200_dkac161-B221","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/myc.12772","article-title":"High terbinafine resistance in Trichophyton interdigitale isolates in Delhi, India harbouring mutations in the squalene epoxidase gene","volume":"61","author":"Singh","year":"2018","journal-title":"Mycoses"},{"key":"2022072817544242200_dkac161-B222","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.02423-17","article-title":"In Vitro Antifungal Activity of Novel Triazole Efinaconazole and Five Comparators against Dermatophyte Isolates","volume":"62","author":"Rezaei-Matehkolaei","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B223","first-page":"615","article-title":"In vitro susceptibility of seven antifungal agents against dermatophytes isolated in \u0130stanbul","volume":"48","author":"Altinba\u015f","year":"2018","journal-title":"Turk J Med Sci"},{"key":"2022072817544242200_dkac161-B224","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/myc.12234","article-title":"Molecular characterization and in vitro antifungal susceptibility of 80 clinical isolates of mucormycetes in Delhi, India","volume":"57","author":"Chowdhary","year":"2014","journal-title":"Mycoses"},{"key":"2022072817544242200_dkac161-B225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.01038-18","article-title":"Correlation of in vitro susceptibility based on MICs and squalene epoxidase mutations with clinical response to terbinafine in patients with tinea corporis\/cruris","volume":"62","author":"Khurana","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B226","volume-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi; Approved Standard\u2014Second Edition: M38-A2","author":"CLSI","year":"2008"},{"key":"2022072817544242200_dkac161-B227","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/jac\/dkaa111","article-title":"Multicentre validation of a EUCAST method for the antifungal susceptibility testing of microconidia-forming dermatophytes","volume":"75","author":"Arendrup","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"2022072817544242200_dkac161-B228","doi-asserted-by":"crossref","first-page":"e02522-17","DOI":"10.1128\/AAC.02522-17","article-title":"Mutation in the Squalene epoxidase gene of Trichophyton interdigitale and Trichophyton rubrum associated with allylamine resistance","volume":"26","author":"Rudramurthy","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B229","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.mycmed.2019.100903","article-title":"A new mutation in the SQLE gene of Trichophyton mentagrophytes associated to terbinafine resistance in a couple with disseminated tinea corporis","volume":"29","author":"Hsieh","year":"2019","journal-title":"J Mycol Med"},{"key":"2022072817544242200_dkac161-B230","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/1346-8138.14809","article-title":"Terbinafine-resistant strain of Trichophyton interdigitale strain isolated from a tinea pedis patient","volume":"46","author":"Hiruma","year":"2019","journal-title":"J Dermatol"},{"key":"2022072817544242200_dkac161-B231","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1099\/jmm.0.46522-0","article-title":"Role of the ABC transporter TruMDR2 in terbinafine, 4-nitroquinoline N-oxide and ethidium bromide susceptibility in Trichophyton rubrum","volume":"55","author":"Fachin","year":"2006","journal-title":"J Med Microbiol"},{"key":"2022072817544242200_dkac161-B232","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1099\/jmm.0.000268","article-title":"Compensatory expression of multidrug-resistance genes encoding ABC transporters in dermatophytes","volume":"65","author":"Martins","year":"2016","journal-title":"J Med Microbiol"},{"key":"2022072817544242200_dkac161-B233","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s11046-018-0242-0","article-title":"Resistance mechanism in a terbinafine-resistant strain of Microsporum canis","volume":"183","author":"Kano","year":"2018","journal-title":"Mycopathologia"},{"key":"2022072817544242200_dkac161-B234","doi-asserted-by":"crossref","first-page":"e00863","DOI":"10.1128\/AAC.00863-19","article-title":"Trichophyton rubrum Azole Resistance Mediated by a New ABC Transporter, TruMDR3","volume":"63","author":"Monod","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B235","first-page":"279","article-title":"Synergistic Effects of Efflux Pump Modulators on the Azole Antifungal Susceptibility of Microsporum canis","volume":"7","author":"Aneke","year":"2020","journal-title":"Mycopathologia"},{"key":"2022072817544242200_dkac161-B236","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/s41598-020-58187-0","article-title":"Rapid detection of terbinafine resistance in Trichophyton species by Amplified refractory mutation system-polymerase chain reaction","volume":"10","author":"Shankarnarayan","year":"2020","journal-title":"Sci Rep"},{"key":"2022072817544242200_dkac161-B237","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0300-2977(96)00061-7","article-title":"The influence of PCP prophylaxis on bacteriuria incidence and resistance development to trimethoprim\/sulfamethoxazole in HIV-infected patients","volume":"49","author":"van Dooyeweert","year":"1996","journal-title":"Neth J Med"},{"key":"2022072817544242200_dkac161-B238","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1368-7646(98)80040-X","article-title":"Drug resistance in Pneumocystis carinii: an emerging problem","volume":"1","author":"Walker","year":"1998","journal-title":"Drug Resist Updat"},{"key":"2022072817544242200_dkac161-B239","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ebiom.2017.06.027","article-title":"Diversity of Pneumocystis jirovecii across Europe: A multicentre observational study","volume":"22","author":"Alanio","year":"2017","journal-title":"EBioMedicine"},{"key":"2022072817544242200_dkac161-B240","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1080\/13693780310001615394","article-title":"Pneumocystis jirovecii dihydropteroate synthase genotypes in French patients with pneumocystosis: a 1998-2001 prospective study","volume":"41","author":"Latouche","year":"2003","journal-title":"Med Mycol"},{"key":"2022072817544242200_dkac161-B241","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1183\/09031936.02.01372002","article-title":"Meta-analysis of diagnostic procedures for Pneumocystis carnii pneumonia in HIV-1-infected patients","volume":"20","author":"Cruciani","year":"2002","journal-title":"Eur Resp J"},{"key":"2022072817544242200_dkac161-B242","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.3201\/eid1010.040362","article-title":"Sulfa use, dihydropteroate synthase mutations, and Pneumocystis jiroveci pneumonia","volume":"10","author":"Stein","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"2022072817544242200_dkac161-B243","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1086\/314509","article-title":"Sequence polymorphisms in the Pneumocystis carinii cytochrome b gene and their association with atovaquone prophylaxis failure","volume":"178","author":"Walker","year":"1998","journal-title":"J Infect Dis"},{"key":"2022072817544242200_dkac161-B244","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1086\/318835","article-title":"Pneumocystis carinii cytochrome b mutations are associated with atovaquone exposure in patients with AIDS","volume":"183","author":"Kazanjian","year":"2001","journal-title":"J Infect Dis"},{"key":"2022072817544242200_dkac161-B245","doi-asserted-by":"crossref","first-page":"e01290-16","DOI":"10.1128\/AAC.01290-16","article-title":"High Prevalence of Pneumocystis jirovecii Dihydropteroate Synthase Gene Mutations in Patients with a First Episode of Pneumocystis Pneumonia in Santiago, Chile, and Clinical Response to Trimethoprim-Sulfamethoxazole Therapy","volume":"61","author":"Ponce","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072817544242200_dkac161-B246","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1086\/655145","article-title":"Interhuman transmission as a potential key parameter for geographical variation in the prevalence of Pneumocystis jirovecii dihydropteroate synthase mutations","volume":"51","author":"Hauser","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2022072817544242200_dkac161-B247","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jhin.2016.01.018","article-title":"Systematic review of outbreaks of Pneumocystis jirovecii pneumonia: evidence that P. jirovecii is a transmissible organism and the implications for healthcare infection control","volume":"93","author":"Yiannakis","year":"2016","journal-title":"J Hosp Infect"},{"key":"2022072817544242200_dkac161-B248","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1007\/s00436-018-6004-6","article-title":"Absence of dihydropteroate synthase gene mutations in Pneumocystis jirovecii strains isolated from Aegean region of Turkey","volume":"117","author":"Ozkoc","year":"2018","journal-title":"Parasitol Res"},{"key":"2022072817544242200_dkac161-B249","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s15010-017-1005-4","article-title":"Low prevalence of DHFR and DHPS mutations in Pneumocystis jirovecii strains obtained from a German cohort","volume":"45","author":"Su\u00e1rez","year":"2017","journal-title":"Infection"},{"key":"2022072817544242200_dkac161-B250","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3201\/eid1901.120140","article-title":"Pneumocystis jirovecii genotype associated with increased death rate of HIV-infected patients with pneumonia","volume":"19","author":"Rabodonirina","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"2022072817544242200_dkac161-B251","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.meegid.2012.11.012","article-title":"Molecular analysis based on mtLSU-rRNA and DHPS sequences of Pneumocystis jirovecii from immunocompromised and immunocompetent patients in Italy","volume":"14","author":"Dimonte","year":"2013","journal-title":"Infect Genet Evol"},{"key":"2022072817544242200_dkac161-B252","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3810\/pgm.2010.11.2219","article-title":"Pneumocystis jiroveci dihydropteroate synthase gene mutations among colonized individuals and Pneumocystis pneumonia patients from Spain","volume":"122","author":"Friaza","year":"2010","journal-title":"Postgrad Med"},{"key":"2022072817544242200_dkac161-B253","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3201\/eid0907.020753","article-title":"Sulfa resistance and dihydropteroate synthase mutants in recurrent Pneumocystis carinii pneumonia","volume":"9","author":"Nahimana","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"2022072817544242200_dkac161-B254","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0924-8579(01)00460-5","article-title":"Mutations in dihydropteroate synthase gene of Pneumocystis carinii in HIV patients with Pneumocystis carinii pneumonia","volume":"18","author":"Visconti","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"2022072817544242200_dkac161-B255","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(99)03320-6","article-title":"Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia","volume":"354","author":"Helweg-Larsen","year":"1999","journal-title":"Lancet"},{"key":"2022072817544242200_dkac161-B256","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jgar.2019.01.007","article-title":"Novel dihydropteroate synthase gene mutation in Pneumocystis jirovecii among HIV-infected patients in India: Putative association with drug resistance and mortality","volume":"17","author":"Singh","year":"2019","journal-title":"J Glob Antimicrob Resist"},{"key":"2022072817544242200_dkac161-B257","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3343\/lmo.2016.6.4.250","article-title":"Case of pneumonia caused by Pneumocystis jirovecii resistant to SXT in the absence of previous drug exposure","volume":"6","author":"Ahn","year":"2016","journal-title":"Lab Med Online"},{"key":"2022072817544242200_dkac161-B258","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.3855\/jidc.6810","article-title":"Molecular detection of DHFR gene polymorphisms in Pneumocystis jirovecii isolates from Indian patients","volume":"9","author":"Singh","year":"2015","journal-title":"J Infect Dev Ctries"},{"key":"2022072817544242200_dkac161-B259","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3347\/kjp.2015.53.3.321","article-title":"A case of pneumonia caused by Pneumocystis jirovecii resistant to trimethoprim-sulfamethoxazole","volume":"53","author":"Lee","year":"2015","journal-title":"Korean J Parasitol"},{"key":"2022072817544242200_dkac161-B260","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.3892\/etm.2014.2002","article-title":"Pneumocystis jirovecii dihydropteroate synthase gene mutations in a group of HIV-negative immunocompromised patients with Pneumocystis pneumonia","volume":"8","author":"Long","year":"2014","journal-title":"Exp Ther Med"},{"key":"2022072817544242200_dkac161-B261","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3855\/jidc.914","article-title":"Dihydropteroate synthase (DHPS) gene mutation study in HIV-Infected Indian patients with Pneumocystis jirovecii pneumonia","volume":"4","author":"Tyagi","year":"2010","journal-title":"J Infect Dev Ctries"},{"key":"2022072817544242200_dkac161-B262","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1128\/JCM.02102-08","article-title":"Clinical significance and phylogenetic relationship of novel Australian Pneumocystis jirovecii genotypes","volume":"47","author":"van Hal","year":"2009","journal-title":"J Clin Microbiol"},{"key":"2022072817544242200_dkac161-B263","first-page":"734","article-title":"Study of dihydropteroate synthase (DHPS) gene mutations among isolates of Pneumocystis jiroveci","volume":"128","author":"Tyagi","year":"2008","journal-title":"Indian J Med Res"},{"key":"2022072817544242200_dkac161-B264","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1128\/JCM.38.9.3161-3164.2000","article-title":"Relationship between mutations in dihydropteroate synthase of Pneumocystis carinii f. sp. hominis isolates in Japan and resistance to sulfonamide therapy","volume":"38","author":"Takahashi","year":"2000","journal-title":"J Clin Microbiol"},{"key":"2022072817544242200_dkac161-B265","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3109\/13693786.2013.770604","article-title":"Dihydropteroate synthase mutations in Pneumocystis pneumonia: impact of applying different definitions of prophylaxis, mortality endpoints and mutant in a single cohort","volume":"51","author":"Yoon","year":"2013","journal-title":"Med Mycol"},{"key":"2022072817544242200_dkac161-B266","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0140-6736(01)05705-1","article-title":"Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P. carinii pneumonia in patients with HIV-1: a prospective study","volume":"358","author":"Navin","year":"2001","journal-title":"Lancet"},{"key":"2022072817544242200_dkac161-B267","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1086\/315824","article-title":"Sulfa or sulfone prophylaxis and geographic region predict mutations in the Pneumocystis carinii dihydropteroate synthase gene","volume":"182","author":"Huang","year":"2000","journal-title":"J Infect Dis"},{"key":"2022072817544242200_dkac161-B268","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/00002030-199808000-00009","article-title":"Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients","volume":"12","author":"Kazanjian","year":"1998","journal-title":"AIDS"},{"key":"2022072817544242200_dkac161-B269","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1371\/journal.pone.0049991","article-title":"International HIV-associated Opportunistic Pneumonias Study. Low prevalence of Pneumocystis pneumonia (PCP) but high prevalence of pneumocystis dihydropteroate synthase (dhps) gene mutations in HIV-infected persons in Uganda","volume":"7","author":"Taylor","year":"2012","journal-title":"PLoS One"},{"key":"2022072817544242200_dkac161-B270","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1128\/JCM.02004-09","article-title":"High prevalence of dihydropteroate synthase mutations in Pneumocystis jirovecii isolated from patients with Pneumocystis pneumonia in South Africa","volume":"48","author":"Dini","year":"2010","journal-title":"J Clin Microbiol"},{"key":"2022072817544242200_dkac161-B271","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.mib.2019.03.001","article-title":"Recent and emerging technologies for the rapid diagnosis of infection and antimicrobial resistance","volume":"51","author":"Trotter","year":"2019","journal-title":"Curr Opin Microbiol"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/77\/8\/2053\/45180560\/dkac161.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/77\/8\/2053\/45180560\/dkac161.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T18:22:55Z","timestamp":1659032575000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/77\/8\/2053\/6608556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,15]]},"references-count":271,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,6,15]]},"published-print":{"date-parts":[[2022,7,28]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkac161","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,8,1]]},"published":{"date-parts":[[2022,6,15]]}}}